Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974791 · ClinicalTrials.gov registry record · NA
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
A NA study of Chronic Pain and Musculoskeletal Pain, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT01974791: Completed NA study of Chronic Pain and Musculoskeletal Pain, sponsored by Boston Children's Hospital.
NCT01974791 is a NA study of Chronic Pain and Musculoskeletal Pain that has completed, run by Boston Children's Hospital. The registered enrollment target is 34 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01974791, a NA study of Chronic Pain and Musculoskeletal Pain, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The broad aim of the study is to implement and evaluate the efficacy of Graded Exposure Treatment (GET Living) to target elevated pain-related fears in children with chronic pain. Pain-related fear is an important psychological factor associated with poor outcomes in children suffering with chronic pain. To examine the efficacy of GET Living in addressing pain-related fears the investigators propose to use a sequential replicated randomized single-case experimental phase design with multiple measures. The specific aims are to 1) evaluate the effectiveness and acceptability of individually tailored GET Living for children with high pain-related fear and functional disability and 2) define anatomical and resting state connectivity patterns in the brains of children and adolescents with complex chronic pain prior to and after participation in GET Living.
Conditions Studied
Interventions
- BEHAVIORAL GET Living
Study Locations (1)
Massachusetts
- Boston Children's Hospital Waltham - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT01974791 record still lists
NCT01974791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which GET Living is the first listed.
NCT01974791 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01974791 about?
NCT01974791 is a clinical study titled "GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain". The broad aim of the study is to implement and evaluate the efficacy of Graded Exposure Treatment (GET Living) to target elevated pain-related fears in children with chronic pain. Pain-related fear is an important psychological factor associated with poor outcomes in children suffering with chronic ...
What is the current status of trial NCT01974791?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2013-10. Estimated completion is 2018-01.
What conditions does trial NCT01974791 study?
This clinical trial studies the following conditions: Chronic Pain, Musculoskeletal Pain, Headache, Neuralgia.
What interventions are being tested in trial NCT01974791?
The interventions under investigation include: GET Living (BEHAVIORAL).
Who is sponsoring clinical trial NCT01974791?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01974791 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01974791's enrollment target sits among peer trials
34 235th of 301 higher than 63 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia